CompanyTrack
E

EPILEPSYGTX LIMITED

Active Canterbury

Research and experimental development on biotechnology

2 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
E

EPILEPSYGTX LIMITED

Research and experimental development on biotechnology

Founded 24 May 2021 Active Canterbury, United Kingdom 2 employees epilepsygtx.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 8 Jul 2025
Confirmation Statement Submitted 11 Jun 2025
Net assets £-410.07K £1.66M 2024 year on year
Total assets £1.33M £413.48K 2024 year on year
Total Liabilities £1.74M £1.24M 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN United Kingdom

Office ()

Cambridge, Cambridgeshire, United Kingdom, Europe

Office (Cambridge Research Park)

Building 1000 Beach Drive Waterbeach Cambridgeshire CB25 9PD

Credit Report

Discover EPILEPSYGTX LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.08M

Decreased by £204.87k (-16%)

Net Assets

-£410.07k

Decreased by £1.66M (-133%)

Total Liabilities

£1.74M

Increased by £1.24M (+252%)

Turnover

N/A

Employees

2

Increased by 1 (+100%)

Debt Ratio

131%

Increased by 103 (+368%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£7k awarded
Show:

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 7,689,766 Shares £2.50m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Oct 20231,500,000£1.50m£1
4 May 20231,000,000£1.00m£1
3 Sept 20212,594,883£25.949£0
3 Sept 20212,594,883£25.949£0

Officers

Officers

6 active 2 resigned
Status
Bernard RavinaDirectorAmericanUnited States581 Aug 2025Active
Caitriona Marie O'rourkeDirectorIrishEngland3929 Feb 2024Active
Dimitri Michael KullmannDirectorBritishUnited Kingdom6724 May 2021Active
Jan Edward ThirkettleDirectorBritishUnited Kingdom549 May 2022Active
Nicolas KoebelDirectorFrench,britishEngland549 Nov 2022Active
Ucltf Corporate Directors LtdCorporate-directorUnited KingdomUnknown17 Feb 2023Active

Shareholders

Shareholders (8)

Utf General Partner 2 Llp (in Its Capacity As A General Partner Of Ucl Technology Fund 2 Lp)
35.4%
4,000,00024 May 2024
Ucl Business Ltd
17.1%
1,933,39724 May 2024
Utf General Partner 2 Llp (in Its Capacity As A General Partner Of Ucl Technology Fund 2 Lp)
13.0%
1,470,72024 May 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased

Utf General Partner 2 Llp

United Kingdom

Active
Notified 10 Feb 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Ucl Business Ltd

United Kingdom

Active
Notified 24 May 2022
Nature of Control
  • Right To Appoint And Remove Directors

Dimitri Michael Kullmann

Ceased 9 May 2022

Ceased

Albion Capital Group Llp

Ceased 23 May 2023

Ceased

Ucl Business Ltd

Ceased 2 Aug 2022

Ceased

Group Structure

Group Structure

UTF GENERAL PARTNER 2 LLP united kingdom voting rights 25 to 50 percent limited liability partnership
UCL BUSINESS LTD united kingdom
UTF ALBION MEMBER 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
UTF ALBION MEMBER LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
ALBION CAPITAL GROUP LLP united kingdom
EPILEPSYGTX LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
4 Nov 2025Change Of NameReplacement filing of SH01 - 02/09/21 Statement of Capital gbp 25.95883View(6 pages)
28 Aug 2025OfficersChange to director Caitriona Marie O'rourke on 2024-11-06View(2 pages)
4 Aug 2025OfficersAppointment of Bernard Ravina as director on 2025-08-01View(2 pages)
8 Jul 2025AccountsAnnual accounts made up to 2024-12-31View(13 pages)
25 Jun 2025OfficersAppointment of Caitriona Marie O'rourke as directorView(3 pages)
4 Nov 2025 Change Of Name

Replacement filing of SH01 - 02/09/21 Statement of Capital gbp 25.95883

28 Aug 2025 Officers

Change to director Caitriona Marie O'rourke on 2024-11-06

4 Aug 2025 Officers

Appointment of Bernard Ravina as director on 2025-08-01

8 Jul 2025 Accounts

Annual accounts made up to 2024-12-31

25 Jun 2025 Officers

Appointment of Caitriona Marie O'rourke as director

Recent Activity

Latest Activity

Replacement filing of SH01 - 02/09/21 Statement of Capital gbp 25.95883

3 months ago on 4 Nov 2025

Change to director Caitriona Marie O'rourke on 2024-11-06

5 months ago on 28 Aug 2025

Appointment of Bernard Ravina as director on 2025-08-01

6 months ago on 4 Aug 2025

Annual accounts made up to 2024-12-31

7 months ago on 8 Jul 2025

Appointment of Caitriona Marie O'rourke as director

7 months ago on 25 Jun 2025